These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 30314924)

  • 41. Medical nutrition therapy in non-alcoholic fatty liver disease--a review of literature.
    Rusu E; Enache G; Jinga M; Dragut R; Nan R; Popescu H; Parpala C; Homentcovschi C; Nitescu M; Stoian M; Costache A; Posea M; Rusu F; Jinga V; Mischianu D; Radulian G
    J Med Life; 2015; 8(3):258-62. PubMed ID: 26351523
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Duodenal-jejunal bypass improves nonalcoholic fatty liver disease independently of weight loss in rodents with diet-induced obesity.
    Angelini G; Castagneto-Gissey L; Casella-Mariolo J; Caristo ME; Russo MF; Lembo E; Verrastro O; Stefanizzi G; Marini PL; Casella G; Bornstein SR; Rubino F; Mingrone G
    Am J Physiol Gastrointest Liver Physiol; 2020 Oct; 319(4):G502-G511. PubMed ID: 32812775
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial.
    Katsagoni CN; Papatheodoridis GV; Ioannidou P; Deutsch M; Alexopoulou A; Papadopoulos N; Papageorgiou MV; Fragopoulou E; Kontogianni MD
    Br J Nutr; 2018 Jul; 120(2):164-175. PubMed ID: 29947322
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An Integrated Understanding of the Rapid Metabolic Benefits of a Carbohydrate-Restricted Diet on Hepatic Steatosis in Humans.
    Mardinoglu A; Wu H; Bjornson E; Zhang C; Hakkarainen A; Räsänen SM; Lee S; Mancina RM; Bergentall M; Pietiläinen KH; Söderlund S; Matikainen N; Ståhlman M; Bergh PO; Adiels M; Piening BD; Granér M; Lundbom N; Williams KJ; Romeo S; Nielsen J; Snyder M; Uhlén M; Bergström G; Perkins R; Marschall HU; Bäckhed F; Taskinen MR; Borén J
    Cell Metab; 2018 Mar; 27(3):559-571.e5. PubMed ID: 29456073
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans.
    Bai J; Xia M; Xue Y; Ma F; Cui A; Sun Y; Han Y; Xu X; Zhang F; Hu Z; Liu Z; Liu Y; Cai G; Su W; Sun X; Wu H; Yan H; Chang X; Hu X; Bian H; Xia P; Gao J; Li Y; Gao X
    EBioMedicine; 2020 Jul; 57():102849. PubMed ID: 32580141
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Involvement of the Autophagy-ER Stress Axis in High Fat/Carbohydrate Diet-Induced Nonalcoholic Fatty Liver Disease.
    Zhou X; Fouda S; Li D; Zhang K; Ye JM
    Nutrients; 2020 Aug; 12(9):. PubMed ID: 32872238
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Very Low-Carbohydrate Ketogenic Diet for the Treatment of Severe Obesity and Associated Non-Alcoholic Fatty Liver Disease: The Role of Sex Differences.
    D'Abbondanza M; Ministrini S; Pucci G; Nulli Migliola E; Martorelli EE; Gandolfo V; Siepi D; Lupattelli G; Vaudo G
    Nutrients; 2020 Sep; 12(9):. PubMed ID: 32916989
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dietary strategies in non-alcoholic fatty liver disease patients: From evidence to daily clinical practice, a systematic review.
    Hadefi A; Arvanitakis M; Trépo E; Zelber-Sagi S
    United European Gastroenterol J; 2023 Sep; 11(7):663-689. PubMed ID: 37491835
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum alanine aminotransferase levels decrease further with carbohydrate than fat restriction in insulin-resistant adults.
    Ryan MC; Abbasi F; Lamendola C; Carter S; McLaughlin TL
    Diabetes Care; 2007 May; 30(5):1075-80. PubMed ID: 17351275
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative efficacy of anti-diabetic agents on nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized and non-randomized studies.
    Tang W; Xu Q; Hong T; Tong G; Feng W; Shen S; Bi Y; Zhu D
    Diabetes Metab Res Rev; 2016 Feb; 32(2):200-16. PubMed ID: 26381272
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of a low-fat diet on the hepatic expression of adiponectin and its receptors in rats with NAFLD.
    Ma H; You GP; Cui F; Chen LF; Yang XJ; Chen LG; Lu HD; Zhang WQ
    Ann Hepatol; 2015; 14(1):108-17. PubMed ID: 25536648
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of Dietary and Lifestyle Interventions on Liver, Clinical and Metabolic Parameters in Children and Adolescents with Non-Alcoholic Fatty Liver Disease: A Systematic Review.
    Katsagoni CN; Papachristou E; Sidossis A; Sidossis L
    Nutrients; 2020 Sep; 12(9):. PubMed ID: 32961669
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nutritional Approaches for the Management of Nonalcoholic Fatty Liver Disease: An Evidence-Based Review.
    Parra-Vargas M; Rodriguez-Echevarria R; Jimenez-Chillaron JC
    Nutrients; 2020 Dec; 12(12):. PubMed ID: 33348700
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatic fat as clinical outcome and therapeutic target for nonalcoholic fatty liver disease.
    Pelusi S; Valenti L
    Liver Int; 2019 Feb; 39(2):250-256. PubMed ID: 30248234
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Improved Diet Quality Associates With Reduction in Liver Fat, Particularly in Individuals With High Genetic Risk Scores for Nonalcoholic Fatty Liver Disease.
    Ma J; Hennein R; Liu C; Long MT; Hoffmann U; Jacques PF; Lichtenstein AH; Hu FB; Levy D
    Gastroenterology; 2018 Jul; 155(1):107-117. PubMed ID: 29604292
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hypocaloric high-protein diet improves clinical and biochemical markers in patients with nonalcoholic fatty liver disease (NAFLD).
    Bezerra Duarte SM; Faintuch J; Stefano JT; Sobral de Oliveira MB; de Campos Mazo DF; Rabelo F; Vanni D; Nogueira MA; Carrilho FJ; Marques Souza de Oliveira CP
    Nutr Hosp; 2014 Jan; 29(1):94-101. PubMed ID: 24483967
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose.
    Sun G; Jackson CV; Zimmerman K; Zhang LK; Finnearty CM; Sandusky GE; Zhang G; Peterson RG; Wang YJ
    BMC Gastroenterol; 2019 Mar; 19(1):41. PubMed ID: 30885145
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comprehensive lifestyle intervention
    Deibert P; Lazaro A; Schaffner D; Berg A; Koenig D; Kreisel W; Baumstark MW; Steinmann D; Buechert M; Lange T
    World J Gastroenterol; 2019 Mar; 25(9):1116-1131. PubMed ID: 30862999
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association Between Magnetic Resonance Imaging-Proton Density Fat Fraction and Liver Histology Features in Patients With Nonalcoholic Fatty Liver Disease or Nonalcoholic Steatohepatitis.
    Wildman-Tobriner B; Middleton MM; Moylan CA; Rossi S; Flores O; Chang ZA; Abdelmalek MF; Sirlin CB; Bashir MR
    Gastroenterology; 2018 Nov; 155(5):1428-1435.e2. PubMed ID: 30031769
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Summary for Patients: Effect of Calorie-Unrestricted Low-Carbohydrate, High-Fat Diet Versus High-Carbohydrate, Low-Fat Diet on Type 2 Diabetes and Nonalcoholic Fatty Liver Disease.
    Ann Intern Med; 2023 Jan; 176(1):I18. PubMed ID: 36508738
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.